Valneva Management
Management criteria checks 0/4
Valneva's CEO is Thomas Lingelbach, appointed in May 2013, has a tenure of 11.5 years. total yearly compensation is €919.56K, comprised of 58.8% salary and 41.2% bonuses, including company stock and options. directly owns 0.24% of the company’s shares, worth €711.33K. The average tenure of the management team and the board of directors is 0.9 years and 1.7 years respectively.
Key information
Thomas Lingelbach
Chief executive officer
€919.6k
Total compensation
| CEO salary percentage | 58.8% |
| CEO tenure | 11.5yrs |
| CEO ownership | 0.2% |
| Management average tenure | less than a year |
| Board average tenure | 1.7yrs |
Recent management updates
Recent updates
Valneva SE's (EPA:VLA) 25% Dip In Price Shows Sentiment Is Matching Revenues
Nov 22
€6.97: That's What Analysts Think Valneva SE (EPA:VLA) Is Worth After Its Latest Results
Nov 10Revenues Working Against Valneva SE's (EPA:VLA) Share Price Following 29% Dive
Sep 19Valneva SE (EPA:VLA) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Aug 17Valneva SE (EPA:VLA) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 10Valneva SE's (EPA:VLA) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Apr 05Analyst Forecasts Just Became More Bearish On Valneva SE (EPA:VLA)
Mar 27Is Valneva (EPA:VLA) Weighed On By Its Debt Load?
Mar 15News Flash: Analysts Just Made A Captivating Upgrade To Their Valneva SE (EPA:VLA) Forecasts
Jan 06Valneva (EPA:VLA) Has Debt But No Earnings; Should You Worry?
Dec 13Does Valneva (EPA:VLA) Have A Healthy Balance Sheet?
Aug 10Valneva SE's (EPA:VLA) Business And Shares Still Trailing The Industry
May 12Valneva (EPA:VLA) Takes On Some Risk With Its Use Of Debt
Jan 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -€7m |
| Jun 30 2024 | n/a | n/a | -€32m |
| Mar 31 2024 | n/a | n/a | -€24m |
| Dec 31 2023 | €920k | €541k | -€101m |
| Sep 30 2023 | n/a | n/a | -€113m |
| Jun 30 2023 | n/a | n/a | -€7m |
| Mar 31 2023 | n/a | n/a | -€135m |
| Dec 31 2022 | €784k | €525k | -€143m |
| Sep 30 2022 | n/a | n/a | €73m |
| Jun 30 2022 | n/a | n/a | -€159m |
| Mar 31 2022 | n/a | n/a | -€72m |
| Dec 31 2021 | €769k | €420k | -€73m |
| Sep 30 2021 | n/a | n/a | -€248m |
| Jun 30 2021 | n/a | n/a | -€125m |
| Mar 31 2021 | n/a | n/a | -€91m |
| Dec 31 2020 | €649k | €376k | -€64m |
| Sep 30 2020 | n/a | n/a | -€62m |
| Jun 30 2020 | n/a | n/a | -€25m |
| Mar 31 2020 | n/a | n/a | -€8m |
| Dec 31 2019 | €1m | €384k | -€2m |
| Sep 30 2019 | n/a | n/a | €4m |
| Jun 30 2019 | n/a | n/a | €1m |
| Mar 31 2019 | n/a | n/a | €7m |
| Dec 31 2018 | €694k | €377k | €3m |
| Sep 30 2018 | n/a | n/a | -€7m |
| Jun 30 2018 | n/a | n/a | -€7m |
| Mar 31 2018 | n/a | n/a | -€8m |
| Dec 31 2017 | €649k | €367k | -€11m |
Compensation vs Market: Thomas's total compensation ($USD969.59K) is above average for companies of similar size in the French market ($USD560.43K).
Compensation vs Earnings: Thomas's compensation has increased whilst the company is unprofitable.
CEO
Thomas Lingelbach (61 yo)
11.5yrs
Tenure
€919,563
Compensation
Mr. Thomas Lingelbach has been the Chief Executive Officer of Valneva SE since May 2013 and served as its Chairman and Member of the Management Board since May 10, 2013 until December 20, 2023 and serves a...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 11.5yrs | €919.56k | 0.24% € 711.3k | |
| Chief Financial Officer | no data | €558.83k | 0.028% € 82.6k | |
| Chief Business Officer | less than a year | €401.34k | 0.39% € 1.2m | |
| Chief Medical Officer | less than a year | €539.76k | 0.028% € 82.6k | |
| Chief Commercial Officer | less than a year | €516.75k | no data | |
| Chief Operating Officer | no data | no data | no data | |
| Chief Scientific Officer | less than a year | no data | no data | |
| Vice President of Investor Relations | 3.3yrs | no data | no data | |
| VP of Global Communications & European Investor Relations | no data | no data | no data | |
| Chief People Officer | less than a year | no data | no data | |
| Head of Global Medical Affairs | no data | no data | no data | |
| Head of Clinical Operations | no data | no data | no data |
0.9yrs
Average Tenure
53yo
Average Age
Experienced Management: VLA's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | €919.56k | 0.24% € 711.3k | |
| Director | less than a year | €74.07k | 0.019% € 56.0k | |
| Member of Scientific Advisory Board | 4.8yrs | €10.00k | no data | |
| Director | less than a year | €66.11k | no data | |
| Director | less than a year | €28.25k | no data | |
| Director | less than a year | no data | no data | |
| Member of Scientific Advisory Board | 5yrs | no data | no data | |
| Chair of Scientific Advisory Board | 5.3yrs | €2.92k | no data | |
| Member of Scientific Advisory Board | 5yrs | no data | no data | |
| Chairman | less than a year | €74.30k | 0.0088% € 26.3k | |
| Member of Scientific Advisory Board | 2.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.5yrs | no data | no data |
1.7yrs
Average Tenure
65yo
Average Age
Experienced Board: VLA's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.